1. Home
  2. FBRX vs ASPN Comparison

FBRX vs ASPN Comparison

Compare FBRX & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$19.12

Market Cap

487.2M

Sector

Health Care

ML Signal

HOLD

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

HOLD

Current Price

$6.39

Market Cap

447.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBRX
ASPN
Founded
N/A
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
RETAIL: Building Materials
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
487.2M
447.5M
IPO Year
2017
2011

Fundamental Metrics

Financial Performance
Metric
FBRX
ASPN
Price
$19.12
$6.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$67.00
$4.25
AVG Volume (30 Days)
178.8K
2.0M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
61.30
N/A
EPS
N/A
N/A
Revenue
$36,000.00
$271,103,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$50.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.78
$2.30
52 Week High
$35.80
$9.78

Technical Indicators

Market Signals
Indicator
FBRX
ASPN
Relative Strength Index (RSI) 32.53 74.49
Support Level $18.18 $3.01
Resistance Level $34.44 $7.23
Average True Range (ATR) 2.09 0.41
MACD -0.22 0.08
Stochastic Oscillator 5.88 81.05

Price Performance

Historical Comparison
FBRX
ASPN

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.

Share on Social Networks: